ClinicalTrials.gg
CompletedNCT07929363Updated Nov 10, 2026

Community Health Promotion for COVID-19 Prevention and NCD Risk Reduction in Rural Sri Lanka

An interventional study of Community-based health promotion programme in COVID 19, Noncommunicable Diseases and Obesity, Abdominal, sponsored by The Foundation for Health Promotion. Completed at 1 site in Sri Lanka. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by The Foundation for Health Promotion · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 5 years 10 months after the study started (first participant enrolled Dec 2020, registered Oct 2026).
Updated Nov 10, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
246
Allocation
Not applicable
Sex
All
01

Study summary

This study evaluated a community health promotion programme, funded by the World Health Organization Sri Lanka Country Office, that addressed COVID-19 prevention and household non-communicable disease (NCD) risk together in six rural villages of Alawwa Divisional Secretariat, Kurunegala District, Sri Lanka, between December 2020 and April 2021. Community groups followed a four-step community-based health promotion process and co-designed three monitoring tools (the Corona Calendar, the Kussi [kitchen] Calendar and the Happiness Calendar). The study describes self-rated household NCD risk before and after initial sessions, baseline waist circumference and kitchen dietary risk, practices reported by families at programme end, and community members' experiences.

Read the detailed description

Seven initial sessions (one in each of six villages and one with a children's group; 246 participants) were followed by 17 follow-up contacts by health promotion facilitators through home visits, telephone and social media. The programme followed four steps: identifying prevention of COVID-19 spread as a collective goal; understanding the determinants of COVID-19 spread and NCD risk; identifying and prioritising actions; and implementing and monitoring actions using indicators agreed with the community.

Data were recorded in aggregated, village-level form: session-mean self-ratings of household NCD risk (0 to 10, 10 = highest risk) at the start and end of the initial session; baseline waist circumference classified against South Asian cut-off points; household kitchen risk classified by the Kussi Calendar (oil, sugar, salt and rice); and counts of families and community members reporting practices at programme end, obtained by telephone and a group discussion. Audio-recorded group discussions in Sinhala were translated into English and analysed thematically.

The study was single-arm with no comparison group, and all analyses were descriptive.

02

Conditions studied

  • COVID 19
  • Noncommunicable Diseases
  • Obesity, Abdominal

Keywords

  • health promotion
  • community engagement
  • community-based health promotion approach
  • dietary behaviour
  • Sri Lanka
03

In context

COVID-19

7,990 studies on the registry are indexed under COVID-19; 466 are open to participants now.

This study's enrollment of 246 is above the median of 102 across 4,364 interventional studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

This is the only study on the registry with The Foundation for Health Promotion as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Resident of one of the six programme villages (Galoliyawa, Welikare, Nallura, Boyawalana, Henduwawa or Pangolla) in Alawwa Divisional Secretariat, Kurunegala District, Sri Lanka
  • Chose to take part in the community health promotion programme

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
246 participants (actual)

Study arms

  • Experimental
    Community health promotion programme

    Community members of six villages and a children's group who took part in the initial sessions and community groups.

    Behavioral: Community-based health promotion programme

Interventions

  • BehavioralCommunity-based health promotion programme

    Initial session on COVID-19 transmission and prevention, the link between NCDs and severe COVID-19, NCD risk factors, family happiness and home gardening; formation of community groups; follow-up contacts by health promotion facilitators; and community co-designed monitoring tools (Corona, Kussi and Happiness Calendars), following a four-step community-based health promotion process.

06

What researchers measure

Primary outcomes

  1. Self-rated household NCD risk

    Session-mean rating by participants of the risk of non-communicable diseases in their own home on a scale of 0 (lowest risk) to 10 (highest risk), recorded at the start and end of the initial session.

    Time frame: Day 1 (immediately before and immediately after the initial session)

  2. Proportion of active families reporting COVID-19 preventive practices

    Number of active families reporting a household handwashing place, removing slippers or changing clothes before entering the house, as a proportion of active families in each village.

    Time frame: Up to 5 months (end of programme)

Secondary outcomes

  1. Proportion of active families reporting dietary changes

    Number of active families reporting reduced consumption of oil, sugar, salt, flour or junk food, or checking E-numbers on packaged food, as a proportion of active families in each village.

    Time frame: Up to 5 months (end of programme)

  2. Community members reporting weight reduction

    Number of community members who monitored their weight and reported a reduction.

    Time frame: Baseline (Day 1) to 5 months (end of programme)

Other outcomes

  1. Waist circumference above cut-off

    Proportion of participants with waist circumference above the cut-off (women more than 80 cm; men more than 90 cm).

    Time frame: Baseline

  2. Household kitchen NCD risk classification

    Proportion of households classified red, orange or green by the Kussi Calendar according to consumption of oil, sugar, salt and rice against household-agreed levels.

    Time frame: Baseline

07

Study locations

1 site
  • Alawwa Divisional Secretariat area (six community villages)
    Alawwa, North Western Province 10640, Sri Lanka
08

References and documents

Individual participant data

Plan to share: No — Only aggregated, village-level data were recorded during the programme; no individual-level participant data exist to share.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07929363
Lead sponsor
The Foundation for Health Promotion
Collaborators
World Health Organization, Rajarata University, Sri Lanka
Responsible party
Prof. Duminda Guruge (Principal Investigator, The Foundation for Health Promotion) — Principal investigator
First posted
Nov 10, 2026
Start date
Dec 1, 2020
Primary completion
Apr 30, 2021
Completion
Apr 30, 2021
Last update
Nov 10, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion